Drug Development Strategies

EPMC helps clients to maximise the chances of rapid marketing approval for their drugs in Europe.  By seeking the advice of scientists at the European Medicines Agency (EMA) prior to the submission of Marketing Approval Applications, our clients achieve a much higher rate of success.

Based on our experience with the process, EPMC can help you to localise drug development plans in order that they may be efficiently read and understood by the official European scientific advisors within the EMA.  Based on their feedback, we manage the required modifications and advise you on how your non-European development plan is most likely to be later approved in Europe.

Once a positive advice has been received, EPMC can also help you later with European Regulatory Procedures to ease your Marketing Approval.

EPMC also acts on behalf of our clients as their Legal Representative in Europe.